Peter Feinberg's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 7,888 Stock Option done . Disclosure was reported to the exchange on Jan. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immuneering Corp (Class A) | Feinberg Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 7,888 | 7,888 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 03 Oct 2025 | 7,500 | 156,766 | - | 6.7 | 50,025 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 7.03 per share. | 30 Sep 2025 | 7,500 | 149,266 | - | 7.0 | 52,730 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 7.18 per share. | 29 Sep 2025 | 5,000 | 141,766 | - | 7.2 | 35,900 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 2.53 per share. | 18 Jun 2025 | 25,000 | 136,766 | - | 2.5 | 63,188 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 33,350 | 33,350 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 23,485 | 23,485 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 33,350 | 33,350 | - | - | Stock Option | |
| Notable Labs Inc | Peter Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 40,247 | 40,247 | - | 0 | Ordinary Shares | |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 22 Mar 2024 | 25,000 | 111,766 | - | 2.5 | 63,713 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 2.31 per share. | 18 Mar 2024 | 45,024 | 56,790 | - | 2.3 | 103,857 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 2.56 per share. | 18 Mar 2024 | 25,000 | 86,766 | - | 2.6 | 64,000 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 18 Mar 2024 | 4,976 | 61,766 | - | 3.1 | 15,201 | Class A Common Stock |
| Notable Labs Inc | Peter Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 9,753 | 9,753 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Feinberg Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 6,879 | 6,879 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 17,500 | 17,500 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 14,200 | 14,200 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 6.75 per share. | 15 Mar 2022 | 6,667 | 11,766 | - | 6.7 | 45,002 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 24.45 per share. | 20 Sep 2021 | 4,750 | 5,099 | - | 24.4 | 116,114 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 21.51 per share. | 13 Sep 2021 | 5,750 | 392,242 | - | 21.5 | 123,697 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 21.25 per share. | 13 Sep 2021 | 349 | 349 | - | 21.2 | 7,416 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 133,572 | 257,325 | - | - | Class A Common Stock | ||
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Aug 2021 | 129,167 | 386,492 | - | 15 | 1,937,505 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Aug 2021 | 129,167 | 476,568 | - | 15 | 1,937,505 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 123,155 | 347,401 | - | - | Class A Common Stock | ||
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 102,926 | 0 | - | - | Series A Preferred Stock | ||
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 92,509 | 0 | - | - | Series A Preferred Stock | ||
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 82,108 | 82,108 | - | - | Class A Common Stock | ||
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 51,462 | 0 | - | - | Series A Preferred Stock | ||
| Immuneering Corp (Class A) | Peter Feinberg | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Aug 2021 | 33,333 | 115,441 | - | 15 | 499,995 | Class A Common Stock |
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 30,646 | 0 | - | - | Series B Preferred Stock | ||
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 30,646 | 0 | - | - | Series B Preferred Stock | ||
| Immuneering Corp (Class A) | Peter Feinberg | Director | 03 Aug 2021 | 30,646 | 0 | - | - | Series B Preferred Stock |